South Korean hospitals are reporting sharp price increases and dwindling stocks of medical consumables due to supply chain disruptions caused by the Iran war.
This crisis threatens the operational stability of healthcare facilities, as essential items like syringes and IV fluids rely on oil-derived naphtha for production. When raw material costs spike and supplies vanish, hospitals face a direct threat to patient care and budget solvency.
Medical supply centers, including Chungbuk National University Hospital, have seen the cost of consumables rise between 15% and 30% [1]. Some specific items have reached the upper limit of that 30% increase [1]. These price hikes are the result of limited manufacturer ability to fulfill orders as the conflict in Iran disrupts the flow of crude oil and naphtha.
Inventory levels have reached critical lows. Current stocks of syringes are estimated to last only two weeks [2]. Other essential medical consumables are projected to last between two and three weeks [3].
Manufacturers have been unable to maintain previous pricing or volume agreements because of the raw-material shortages. The reliance on naphtha, a petroleum distillate, means that geopolitical instability in oil-producing regions translates directly into a shortage of plastic-based medical tools.
Hospitals are now forced to manage strained budgets while attempting to secure remaining stock before inventories are completely exhausted. The current trend suggests that prices will remain elevated as long as the conflict impacts the global oil market.
“Prices of medical consumables have risen between 15% and 30%.”
This situation highlights the vulnerability of modern healthcare infrastructure to geopolitical volatility. Because basic medical tools are essentially petrochemical products, a conflict in the Middle East can trigger a healthcare crisis in East Asia, transforming an energy shortage into a clinical shortage.
